| Financial Year |
March 31 2023 |
| Monetary Funds |
1,381,339,296.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,718,140.38 |
| Accounts Receivable |
531,656,670.52 |
| Advances to Suppliers |
26,804,590.15 |
| Other Receivables |
21,947,927.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
255,253,516.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
45,116,219.73 |
| Other Current Assets |
30,121,175.95 |
| Total Current Assets |
2,296,957,537.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
48,065,574.25 |
| Long-term Equity Investment |
227,878,733.53 |
| Investment Properties |
254,358,553.57 |
| Fixed Assetes |
619,830,015.14 |
| Under-construction Projects |
26,543,068.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,393,699.77 |
| R&D expenses |
29,060,299.31 |
| Goodwill |
702,913,535.62 |
| Long-Term Deferred and Prepaid Expenses |
115,706,254.79 |
| Deferred Income Tax Assets |
56,055,204.62 |
| Other Non-Current Assets |
70,173,534.00 |
| Sub-Total of Non-Current Assets |
2,950,834,014.00 |
| Total Assets |
5,247,791,551.14 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
86,813,034.13 |
| Accounts Received In Advance |
1,836,807.49 |
| Employee Compensation Payable |
32,258,910.25 |
| Taxes Payable |
52,853,216.03 |
| Interest Payable |
-- |
| Dividend Payable |
2,842,853.99 |
| Other payables |
49,747,440.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,930,681.62 |
| Other Current Liabilities |
50,533,433.62 |
| Sub-Total of Current Liabilities |
1,412,669,461.64 |
| Long-term Loans |
15,772,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,600,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,029,209.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
159,181,506.55 |
| Total Liabilities |
1,571,850,968.19 |
| Paid-In Capital(Or Share Stock) |
467,948,890.00 |
| Capital Surplus |
3,380,123,620.24 |
| Surplus Reserve |
23,157,390.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-386,511,111.06 |
| Minority Stockholder's Interest |
98,734,846.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,577,205,736.94 |
| Owner's Equity（Stockholder's Equity） |
3,675,940,582.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,247,791,551.14 |
